Dr Absar Khalid Mir; Dr Mohammad Ahmad Abbasi; Dr Laiba Mustansar Sahi; Dr Samana Batool; Dr Muhammad Bilal Anwar; Dr Tehreem Ali; Dr Abeera Kazmi; Dr Israa Alam; Dr Muhammad Ali Hassan. EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. J Popl Ther Clin Pharmacol 2024, 31 (6), 1059-1065. https://doi.org/10.53555/jptcp.v31i6.6611.